Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (ALNY) Q4 2021 Earnings
ALNY
-0.07%
28
Oct
Confirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-2.09
-1.91
-1.74
-1.56
Details
Expected EPS
-1.56
Actual EPS
-1.64
Surprise EPS
-0.08
Surprise Percent
+5.13%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.64 per share for Q4 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login